연구용제품시약 > 기타
[Bioss 한국 단독 대리점] Recombinant SARS-COV-2 Spike S1
바이오클론
한국 독점 대리점:바이오클론 (주) ( www.bioclone.co.kr )
* 20만여개의 제품 보유
* Alexa Flour/350/488/555/594/647, Cy3/5/5.5/7, FITC, HRP, PE 등의 다양한 Fluorescence Dye와 conjugation된 antibody 제공
* WB, ELISA, IHC-P, IF, FCM 등의 다양한 Application
[ Products ]
Primary Antibodies
Secondary Antibodies
Isotype Controls
Enhandced Cell Counting Kit-8
Recombinant SARS-COV-2 Spike S1 (D614G) Protein
Cat no. bs-46010P
OVERVIEW | |
CATALOG # | bs-46010P |
PRODUCT NAME |
Recombinant SARS-COV-2 Spike S1 (D614G) Protein
|
CONJUGATION | Unconjugated |
SOURCE | SARS-COV-2 Spike S1 (D614G) Protein is expressed with a His-tag and Avi at the C-terminal. It contains (Gln14-Arg683). |
EXPRESSION SYSTEM | HEK293 |
TAG | His-Avi |
MOLECULAR WEIGHT | The protein has a predicted MW of 77.9 kDa. Due to glycosylation, the protein migrates to 110-120KDa based on the Bis-Tris PAGE result. |
ENDOTOXIN | Less than 1EU per ug by the LAL method. |
PURITY: | > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC |
FORMULATION | Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5 % trehalose is added as a protectant before lyophilization. |
STORAGE | The product should be stored at -70℃ or -20℃. |
TARGET | |
ACCESSION | QHD43416.1 |
BACKGROUND | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |
본 정보는 "바이오클론" (으)로 문의 바랍니다.